Literature DB >> 3005203

The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription.

M Seiki, J Inoue, T Takeda, A Hikikoshi, M Sato, M Yoshida.   

Abstract

Human T-cell leukemia virus type I has a unique sequence pX and the product p40x was proposed to be a specific trans-acting transcriptional activator of expression of the viral gene. Recently, a second pX protein p27x-III in addition to p40x was identified; these two proteins are encoded by overlapping frames III and IV (x-lor). For determination of which product is the trans-acting activator, site-directed mutations were introduced into the pX sequence which was placed under the metallothionein promoter. On cotransfection with pLTR-CAT (a plasmid containing the LTR of HTLV-I and chloramphenicol acetyltransferase gene), only the mutations that affected p40x expression inactivated the transcriptional activation from the LTR.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3005203

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

1.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

2.  Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene.

Authors:  A Lilienbaum; M Duc Dodon; C Alexandre; L Gazzolo; D Paulin
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.

Authors:  J Inoue; M Yoshida; M Seiki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  A single species of pX mRNA of human T-cell leukemia virus type I encodes trans-activator p40x and two other phosphoproteins.

Authors:  K Nagashima; M Yoshida; M Seiki
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription.

Authors:  K Shimotohno; M Takano; T Teruuchi; M Miwa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

6.  Response of the human T-cell leukemia virus type 1 long terminal repeat to cyclic AMP.

Authors:  H T Poteat; P Kadison; K McGuire; L Park; R E Park; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes.

Authors:  H Akaoka; H Hardin-Pouzet; A Bernard; B Verrier; M F Belin; P Giraudon
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax.

Authors:  T Tsukahara; M Kannagi; T Ohashi; H Kato; M Arai; G Nunez; Y Iwanaga; N Yamamoto; K Ohtani; M Nakamura; M Fujii
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax protein.

Authors:  A Salvetti; A Lilienbaum; Z Li; D Paulin; L Gazzolo
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

10.  Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator.

Authors:  M Seiki; J Inoue; T Takeda; M Yoshida
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.